Streetbeat News

Stock Prices

C

Recent options activity for Citigroup (NYSE:C) shows a significant bearish sentiment, with 75% of trades being bearish. The options trades include both puts and calls, with a price range target of $52.5 to $70.0. Citigroup's stock is currently trading at $61.27, down by 1.23%. An analyst from Morgan Stanley maintains an Overweight rating with a target price of $79.

Portfolio Pulse from Benzinga Insights

August 20, 2024 | 4:31 pm

SAIA

Saia (NASDAQ:SAIA) has significantly outperformed the market over the past 15 years, with an average annual return of 25.86%. A $100 investment in Saia 15 years ago would now be worth $3,136.35, highlighting the power of compounded returns.

Portfolio Pulse from Benzinga Insights

August 20, 2024 | 4:30 pm

TTD

Trade Desk (NASDAQ:TTD) has significantly outperformed the market over the past 5 years, with an average annual return of 32.57%. A $1000 investment in TTD 5 years ago would now be worth $4,168.32, highlighting the power of compounded returns.

Portfolio Pulse from Benzinga Insights

August 20, 2024 | 4:30 pm

HTHT

H World Group Limited (NASDAQ:HTHT) shares fell after Q2 earnings and sales missed expectations. The company reported adjusted earnings per ADS of 53 cents, below the expected 74 cents, and sales of $846 million, missing the $956.48 million forecast. Despite a year-over-year revenue increase of 11.2%, the stock dropped 4.39% to $27.75. The company anticipates modest revenue growth in Q3 and has increased its hotel opening forecast for 2024.

Portfolio Pulse from Nabaparna Bhattacharya

August 20, 2024 | 4:26 pm

CRWD

IBM

PANW

Palo Alto Networks (PANW) reported strong earnings, leading to a rise in its stock price. Analysts have raised their price targets, citing solid revenue growth and platformization strategy. The company's guidance for fiscal 2025 was slightly below expectations but still positive.

Portfolio Pulse from Priya Nigam

August 20, 2024 | 4:24 pm

EL

Estée Lauder Companies Inc (NYSE:EL) reported mixed Q4 results, with organic growth slightly exceeding expectations but facing challenges in the Americas and APAC regions. Analysts have mixed ratings, with price targets adjusted downwards. The company anticipates a transition year in fiscal 2025, with potential improvements expected later in the year.

Portfolio Pulse from Priya Nigam

August 20, 2024 | 4:24 pm

SNY

SPRY

ARS Pharmaceuticals' Neffy, an epinephrine nasal spray, has been approved by the FDA for emergency allergic reactions. Cantor Fitzgerald initiated coverage with an Overweight rating and a $30 price target, citing Neffy's potential to capture 30% market share and change the allergy treatment paradigm.

Portfolio Pulse from Vandana Singh

August 20, 2024 | 4:21 pm

MMM

Josh Brown, on CNBC, expressed a bullish outlook for 3M, suggesting that the company is poised for a breakout. This was discussed during a segment titled 'The Bull Case For 3M'.

Portfolio Pulse from Benzinga Newsdesk

August 20, 2024 | 4:20 pm

CVX

HES

IYE

XLE

XOM

An arbitration panel is set to examine the hidden value of Hess Corporation's oil assets in Guyana amidst a dispute between Exxon Mobil and Chevron. The conflict revolves around whether the deal triggers Exxon's right of first refusal, potentially affecting Chevron's $53 billion acquisition of Hess. Exxon is considering a counterbid if the arbitration supports their claim. The decision is expected in the second half of 2025.

Portfolio Pulse from Lekha Gupta

August 20, 2024 | 4:16 pm

CRM

Deep-pocketed investors are showing a bearish sentiment towards Salesforce (NYSE:CRM) as revealed by Benzinga's options scanner. The options activity is unusual, with 57% of trades being bearish. The stock is currently down 0.95% at $262.86, and RSI indicators suggest it may be overbought. An analyst from B of A Securities maintains a Buy rating with a target price of $316.

Portfolio Pulse from Benzinga Insights

August 20, 2024 | 4:16 pm